Actionable news
All posts from Actionable news
Actionable news in FOLD: Amicus Therapeutics, Inc.,

Amicus (FOLD) CEO Crowley to CNBC: 'Our Job is to Stay Focused and Keep Making Great Medicines'

NEW YORK (TheStreet) --Amicus Therapeutics, (FOLD) a drug manufacturing company specializing in medicines for rare diseases, reported lower-than-expected 2016 second-quarter earnings after the opening bell on Tuesday. The company posted an earnings loss of 40 cents per share, wider than the projected loss of 33 cents per share. Amicus did not report revenue, despite consensus estimates of $170,000 in sales for the quarter.

Amicus' CEO John Crowley joined CNBC's "Squawk...